Is There a “Best” Dental Implant Company? What the Question Actually Needs to Answer

“Best dental implant company” is one of the most common searches in implant dentistry, and it rarely gets a useful answer — because the honest answer is that no single company is best across every dimension that matters to a clinic. A company can lead the field in published clinical evidence while a competitor leads in price-to-component-quality ratio, and a third leads in digital workflow integration. Treating this as a single ranking question, rather than a multi-dimensional fit question, is exactly how clinics end up choosing a supplier based on the most persuasive sales conversation rather than the criteria that will actually matter five years into using the system.

At Edison Medical, we’d rather help a clinic ask this question correctly than offer a confident, oversimplified answer to a question that doesn’t have one. This article breaks down what “best” actually needs to mean, gives a neutral picture of where the major players in the market currently stand, and offers a framework for deciding which company is the right fit for a specific practice.

Why “Best” Is the Wrong Starting Question

A ranking implies a single, shared scale, but dental implant companies compete on genuinely different axes: clinical evidence depth, connection biomechanics, surface technology, digital ecosystem integration, manufacturing scale and pricing, component compatibility breadth, and customer support quality, among others. A company that scores highest on one axis frequently does not score highest on another — and which axis matters most depends entirely on the type of practice asking the question. A high-volume general practice doing routine single-tooth cases has a different optimal answer than a full-arch-focused specialty clinic, which has a different optimal answer again from a clinic in a market with thin third-party component availability and a real need for long-term serviceability.

This is the same logic applied earlier in evaluating implant systems, but it applies with even more force at the company level, because a company decision also brings in factors that have nothing to do with any individual implant’s mechanical properties: financial stability, regional distribution and support infrastructure, training programs, and how the company has historically handled product transitions and legacy component support.

The Current Market Landscape, Neutrally Stated

A handful of companies hold the largest share of the global dental implant market, and it is useful to understand their general positioning without treating any of this as a ranking.

Straumann Group holds a leading share of the European market and has built a long-standing clinical research relationship with the International Team for Implantology (ITI), with a large body of published, multi-decade clinical literature behind its core implant lines and conical connection systems.

Dentsply Sirona positions itself around a broad, integrated dental technology ecosystem — combining implants with imaging, CAD/CAM (CEREC), and broader restorative and equipment lines — appealing particularly to practices wanting a single-vendor digital workflow across multiple disciplines, not just implants.

Nobel Biocare, now under Envista, holds a strong position in North America and is closely associated with the All-on-4 treatment concept and the multi-unit abutment system that supports it, alongside a long track record in full-arch implant prosthetics.

Osstem Implant became the largest implant manufacturer globally by volume by the mid-2020s, built substantially around competitive pricing and rapid international expansion, particularly across Asia and increasingly into North American and European markets.

ZimVie and a number of other established manufacturers occupy a meaningful next tier, often differentiating on specific connection technologies, pricing position, or regional specialization.

None of this constitutes a ranking of clinical quality — market share reflects commercial scale, distribution reach, and pricing strategy as much as it reflects biomechanical performance, and a smaller company with a narrower but well-evidenced product line is not automatically a worse clinical choice than a larger one. What this landscape does illustrate is that the companies competing for a clinic’s business genuinely emphasize different things, which reinforces the point that “best” depends on what a specific practice is optimizing for.

What “Best” Should Actually Be Evaluated Against

Rather than asking which company is best in the abstract, a more useful set of questions evaluates fit against a practice’s actual needs:

Evidence depth on the specific product line in use. A company’s overall reputation does not automatically transfer to every product line it sells — a long-established company can still have a comparatively new, thinly evidenced implant line, and a newer company can have surprisingly strong data on a specific, well-studied system. The question to ask is about the specific implant and connection system under consideration, not the company’s brand reputation as a whole.

Component ecosystem longevity and breadth. A company’s commitment to keeping legacy components available and compatible matters enormously for cases placed today that will need servicing a decade from now. This is harder to evaluate than headline product specs, but asking how a company has handled discontinued product lines historically — and whether component availability for older systems remains realistic — is a fair and important question.

Regional support and distribution reliability. A company with excellent products but unreliable shipping, weak regional technical support, or limited training infrastructure in a clinic’s specific market creates real day-to-day friction that product specifications alone do not capture. This varies considerably by region even for the largest global companies.

Pricing structure relative to total case cost. As with individual implant systems, company-level pricing comparisons should account for the full restorative component list a typical case requires, not just headline implant pricing, since some companies price implants competitively while pricing prosthetic components, screws, or proprietary digital workflow tools at a premium.

Alignment with the clinic’s case mix. A company strongest in full-arch, All-on-4-style protocols is a different optimal choice for a clinic focused on that work than for a practice doing predominantly single-tooth restorations in routine anatomical sites, even if both companies are reputable in absolute terms.

Red Flags Worth Treating Skeptically

Independent of which company a clinic is evaluating, a few patterns are worth scrutinizing regardless of source: claims of categorical superiority (“the strongest connection on the market,” “zero complications”) unsupported by specific, citable peer-reviewed data; marketing material that emphasizes brand prestige or sales volume rather than the specific clinical evidence behind the product line in question; and pressure to commit to a single-supplier ecosystem before a clinic has had the chance to evaluate component compatibility, digital workflow fit, and realistic long-term servicing independently. These patterns are not unique to any one company — they appear across the industry, including, at times, among the most established names — and a clinic’s evaluation process should be built to catch them regardless of source.

A Fit-Based Decision Framework

Given that no universal ranking exists, a more productive approach for a clinic is to score candidate companies against criteria weighted to the practice’s actual situation:

Criterion	Questions worth asking
Clinical evidence	What peer-reviewed, multi-year data exists on the specific product line, not just the company overall?
Connection biomechanics	Does the system’s connection design align with the biomechanical trade-offs the practice’s case mix needs?
Component ecosystem	How broad and durable is the prosthetic component range, and how dependent is it on a single supplier?
Digital workflow	Is the system well supported across the scanning and CAD platforms the practice already uses?
Total cost of ownership	What does a representative full case cost, not just the headline implant price?
Regional support	What is the company’s actual service, training, and shipping track record in this specific market?
Case-mix alignment	Does the company’s strongest evidence and component support match the kind of cases this practice does most?

Conclusion

There is no single “best” dental implant company, and any answer claiming otherwise is simplifying past the point of usefulness. There are companies that are demonstrably strong on specific, verifiable dimensions — clinical evidence depth, full-arch protocol support, digital ecosystem integration, manufacturing scale and pricing — and the right choice for any individual practice depends on which of those dimensions matter most for the cases that practice actually does. A clinic that evaluates candidate suppliers against a structured, fit-based framework, rather than a single overall reputation, will consistently make a better long-term decision than one chasing a ranking that the evidence doesn’t actually support.

At Edison Medical, we’d rather a clinic evaluate us — and every other company under consideration — against this kind of structured criteria than against a marketing claim of being “the best.” We make our dental implants, impression and lab components, multi-unit screw-retained parts, and overdenture attachment systems available for exactly that kind of direct, criteria-based comparison.